Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 6 minute read Pharma Industry News XORTX surges after $3M Vectus Biosystems deal adds promising anti-fibrotic kidney drug to pipeline Find out how XORTX’s $3 million Vectus Biosystems acquisition could reshape the renal fibrosis market and accelerate its transformation into a leading kidney disease innovator. bySoujanya RaviOctober 17, 2025